Aging and Cardiovascular Health: CVIA State-of-the-Art Review

Abstract

Aging is an inevitable biological process marked by progressive functional decline and elevated risk of cardiovascular diseases (CVDs). This review systematically examines the clinical mechanisms linking aging to cardiovascular pathology, focusing on molecular, cellular, and physiological changes that contribute to cardiovascular aging, which in turn increases the incidence of heart failure, atherosclerosis, atrial fibrillation, and other diseases. Key mechanisms include metabolic dysregulation, mitochondrial dysfunction, chronic inflammation, cellular senescence, immune disorders, and epigenetic changes. Understanding these mechanisms is crucial for developing targeted interventions to delay cardiovascular aging and alleviate CVD burden in older people. Current therapeutic strategies, including lifestyle modifications, pharmacotherapy, gerotherapeutic interventions, and device-based management, are reviewed, along with future directions in precision medicine, development of novel therapeutic targets, multi-omics, and AI-powered strategies against cardiovascular aging.

Keywords

Cardiovascular diseases / Cardiovascular aging / Cellular senescence / Multidimensional mechanisms / Therapeutic interventions

References

[1] United Nations Department of Economic and Social Affairs PD. World population prospects 2022: summary of results.

[2] Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al.. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020. Vol. 76(25):2982-3021

[3] Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a “set up” for vascular diseas. Circulation. 2003. Vol. 107(1):139-46

[4] Dou H, Feher A, Davila AC, Romero MJ, Patel VS, Kamath VM, et al.. Role of adipose tissue endothelial ADAM17 in age-related coronary microvascular dysfunction. Arterioscler Thromb Vasc Biol. 2017. Vol. 37(6):1180-93

[5] Tchkonia T, Kirkland JL. Aging, cell senescence, and chronic disease: emerging therapeutic strategies. J Am Med Assoc. 2018. Vol. 320(13):1319-20

[6] Childs BG, Durik M, Baker DJ, van Deursen JM. Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat Med. 2015. Vol. 21(12):1424-35

[7] Schafer MJ, White TA, Iijima K, Haak AJ, Ligresti G, Atkinson EJ, et al.. Cellular senescence mediates fibrotic pulmonary disease. Nat Commun. 2017. Vol. 8(1):14532

[8] Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al.. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017. Vol. 377(12):1119-31

[9] Lunnon K, Smith R, Hannon E, De Jager PL, Srivastava G, Volta M, et al.. Methylomic profiling implicates cortical deregulation of ANK 1 in Alzheimer’s disease. Nat Neurosci. 2014. Vol. 17(9):1164-70

[10] Haycock PC, Burgess S, Nounu A, Zheng J, Okoli GN, Bowden J, et al.. Association between telomere length and risk of cancer and non-neoplastic diseases: a mendelian randomization study. JAMA Oncol. 2017. Vol. 3(5):636-51

[11] Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013. Vol. 14(10):3156

[12] Hannum G, Guinney J, Zhao L, Zhang L, Hughes G, Sadda S, et al.. Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol Cell. 2013. Vol. 49(2):359-67

[13] Fong S, Denisov KA, Nefedova AA, Kennedy BK, Gruber J. LinAge2: providing actionable insights and benchmarking with epigenetic clocks. NPJ Aging. 2025. Vol. 11(1):29

[14] Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, et al.. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016. Vol. 17(12):1321-60

[15] Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al.. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006. Vol. 27(21):2588-605

[16] Lodin K, Oliveira Da Silva C, Bulatovic I, Haugaa K, Ruck A, Eriksson M, et al.. Abstract 4370029: imaging markers of myocardial fibrosis in mitral valve prolapse across stages of mitral regurgitation severity. Circulation. 2025. Vol. 152 Suppl 3:A4370029-A

[17] Topriceanu CC, Webber M, Shiwani H, Chan F, Martin E, Falconer D, et al.. Higher life-course blood pressure associates with reduced myocardial perfusion in older age: insights from MyoFit46. Circ Cardiovasc Imaging. 2026. Vol. 19(2):e019105

[18] Shah ASV, Keene SJ, Pennells L, Kaptoge S, Kimenai DM, Walker M, et al.. Cardiac troponins and cardiovascular disease risk prediction: an individual-participant-data meta-analysis. J Am Coll Cardiol. 2025. Vol. 85(14):1471-84

[19] Rutten JH, Mattace-Raso FU, Steyerberg EW, Lindemans J, Hofman A, Wieberdink RG, et al.. Amino-terminal pro-B-type natriuretic peptide improves cardiovascular and cerebrovascular risk prediction in the population: the Rotterdam study. Hypertension. 2010. Vol. 55(3):785-91

[20] Lai HY, Huang ST, Anker SD, von Haehling S, Akishita M, Arai H, et al.. The burden of frailty in heart failure: prevalence, impacts on clinical outcomes and the role of heart failure medications. J Cachexia Sarcopenia Muscle. 2024. Vol. 15(2):660-70

[21] Premaor MO, Mendes SA, Vieira GHSA, Braga CD, Santos AF, Ferreira DSA, et al.. People with heart failure, sarcopenia and chagas disease: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2025. Vol. 19(11):e0013699

[22] Zhao MQ, Shen T, Zhao ML, Liu JX, Xu ML, Li X, et al.. Cognitive function disparities among atrial fibrillation patients with varying comorbidities. J Geriatr Cardiol. 2025. Vol. 22(10):859-70

[23] Yamada S, Adachi T, Izawa H, Murohara T, Kondo T. Prognostic score based on physical frailty in patients with heart failure: a multicenter prospective cohort study (FLAGSHIP). J Cachexia Sarcopenia Muscle. 2021. Vol. 12(6):1995-2006

[24] Çelik MC, Kalçık M, Birgün A, Yetim M, Bekar L, Karavelioğlu Y. Endothelial dysfunction and vascular stiffness: molecular drivers of cardiovascular aging. Explor Cardiol. 2025. Vol. 3:101279

[25] Donato AJ, Machin DR, Lesniewski LA. Mechanisms of dysfunction in the aging vasculature and role in age-related disease. Circ Res. 2018. Vol. 123(7):825-48

[26] Das A, Huang GX, Bonkowski MS, Longchamp A, Li C, Schultz MB, et al.. Impairment of an endothelial NAD⁺-H₂S signaling network is a reversible cause of vascular aging. Cell. 2018. Vol. 173(1):74-89.e20

[27] Faber JE, Zhang H, Lassance-Soares RM, Prabhakar P, Najafi AH, Burnett MS, et al.. Aging causes collateral rarefaction and increased severity of ischemic injury in multiple tissues. Arterioscler Thromb Vasc Biol. 2011. Vol. 31(8):1748-56

[28] Ungvari Z, Podlutsky A, Sosnowska D, Tucsek Z, Toth P, Deak F, et al.. Ionizing radiation promotes the acquisition of a senescence-associated secretory phenotype and impairs angiogenic capacity in cerebromicrovascular endothelial cells: role of increased DNA damage and decreased DNA repair capacity in microvascular radiosensitivity. J Gerontol A Biol Sci Med Sci. 2013. Vol. 68(12):1443-57

[29] Libby P. Interleukin-1 beta as a target for atherosclerosis therapy: biological basis of CANTOS and beyond. J Am Coll Cardiol. 2017. Vol. 70(18):2278-89

[30] De Ciuceis C, Amiri F, Brassard P, Endemann DH, Touyz RM, Schiffrin EL. Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury. Arterioscler Thromb Vasc Biol. 2005. Vol. 25(10):2106-13

[31] Wu D, Hu Q, Liu X, Pan L, Xiong Q, Zhu YZ. Hydrogen sulfide protects against apoptosis under oxidative stress through SIRT1 pathway in H9c2 cardiomyocytes. Nitric Oxide. 2015. Vol. 46:204-12

[32] Kolluru GK, Shackelford RE, Shen X, Dominic P, Kevil CG. Sulfide regulation of cardiovascular function in health and disease. Nat Rev Cardiol. 2023. Vol. 20(2):109-25

[33] Larsson LG. Oncogene-and tumor suppressor gene-mediated suppression of cellular senescence. Semin Cancer Biol. 2011. Vol. 21(6):367-76

[34] Coppé JP, Patil CK, Rodier F, Sun Y, Muñoz DP, Goldstein J, et al.. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p 53 tumor suppressor. PLoS Biol. 2008. Vol. 6(12):2853-68

[35] Coppé JP, Desprez PY, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol. 2010. Vol. 5:99-118

[36] Childs BG, Baker DJ, Wijshake T, Conover CA, Campisi J, van Deursen JM. Senescent intimal foam cells are deleterious at all stages of atherosclerosis. Science. 2016. Vol. 354(6311):472-7

[37] Wang J, Uryga AK, Reinhold J, Figg N, Baker L, Finigan A, et al.. Vascular smooth muscle cell senescence promotes atherosclerosis and features of plaque vulnerability. Circulation. 2015. Vol. 132(20):1909-19

[38] Xu M, Pirtskhalava T, Farr JN, Weigand BM, Palmer AK, Weivoda MM, et al.. Senolytics improve physical function and increase lifespan in old age. Nat Med. 2018. Vol. 24(8):1246-56

[39] Picos A, Seoane N, Campos-Toimil M, Vina D. Vascular senescence and aging: mechanisms, clinical implications, and therapeutic prospects. Biogerontology. 2025. Vol. 26(3):118

[40] Chen J, Huang X, Halicka D, Brodsky S, Avram A, Eskander J, et al.. Contribution of p16^INK4a and p21^CIP1 pathways to induction of premature senescence of human endothelial cells: permissive role of p53. Am J Physiol Heart Circ Physiol. 2006. Vol. 290(4):H1575-86

[41] Kovacic JC, Dimmeler S, Harvey RP, Finkel T, Aikawa E, Krenning G, et al.. Endothelial to mesenchymal transition in cardiovascular disease: JACC state-of-the-art review. J Am Coll Cardiol. 2019. Vol. 73(2):190-209

[42] Freund A, Orjalo AV, Desprez PY, Campisi J. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol Med. 2010. Vol. 16(5):238-46

[43] Pescatore LA, Gamarra LF, Liberman M. Multifaceted mechanisms of vascular calcification in aging. Arterioscler Thromb Vasc Biol. 2019. Vol. 39(7):1307-16

[44] Mitchell GF. Arterial stiffness and hypertension. Hypertension. 2014. Vol. 64(1):13-8

[45] Martin-Fernandez B, Gredilla R. Mitochondria and oxidative stress in heart aging. Age (Dordr). 2016. Vol. 38(4):225-38

[46] Chiao YA, Rabinovitch PS. The aging heart. Cold Spring Harb Perspect Med. 2015. Vol. 5(9):a025148

[47] Hoes MF, Grote Beverborg N, Kijlstra JD, Kuipers J, Swinkels DW, Giepmans BNG, et al.. Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function. Eur J Heart Fail. 2018. Vol. 20(5):910-9

[48] Makrecka-Kuka M, Korzh S, Videja M, Vilskersts R, Sevostjanovs E, Zharkova-Malkova O, et al.. Inhibition of CPT2 exacerbates cardiac dysfunction and inflammation in experimental endotoxaemia. J Cell Mol Med. 2020. Vol. 24(20):11903-11

[49] Zhang P, Guan P, Ye X, Lu Y, Hang Y, Su Y, et al.. SOCS6 promotes mitochondrial fission and cardiomyocyte apoptosis and is negatively regulated by quaking-mediated miR-19b. Oxid Med Cell Longev. 2022. Vol. 2022:1121323

[50] Gandoy-Fieiras N, Gonzalez-Juanatey JR, Eiras S. Myocardium metabolism in physiological and pathophysiological states: implications of epicardial adipose tissue and potential therapeutic targets. Int J Mol Sci. 2020. Vol. 21(7):2641

[51] Tsilingiris D, Tzeravini E, Koliaki C, Dalamaga M, Kokkinos A. The role of mitochondrial adaptation and metabolic flexibility in the pathophysiology of obesity and insulin resistance: an updated overview. Curr Obes Rep. 2021. Vol. 10(3):191-213

[52] Ozaki N, Sato E, Kurokawa T, Ishibashi S. Early changes in the expression of GLUT 4 protein in the heart of senescence-accelerated mouse. Mech Ageing Dev. 1996. Vol. 88(3):149-58

[53] Papachristoforou E, Lambadiari V, Maratou E, Makrilakis K. Association of glycemic indices (hyperglycemia, glucose variability, and hypoglycemia) with oxidative stress and diabetic complications. J Diabetes Res. 2020. Vol. 2020:7489795

[54] Zhao P, Yue Z, Nie L, Zhao Z, Wang Q, Chen J, et al.. Hyperglycaemia-associated macrophage pyroptosis accelerates periodontal inflamm-aging. J Clin Periodontol. 2021. Vol. 48(10):1379-92

[55] Zhu C, Gu H, Jin Y, Wurm D, Freidhof B, Lu Y, et al.. Metabolomics of oxidative stress: Nrf2 independent depletion of NAD or increases of sugar alcohols. Toxicol Appl Pharmacol. 2022. Vol. 442:115949

[56] Scavello F, Zeni F, Milano G, Macrì F, Castiglione S, Zuccolo E, et al.. Soluble receptor for advanced glycation End-products regulates age-associated Cardiac Fibrosis. Int J Biol Sci. 2021. Vol. 17(10):2399-416

[57] Bakris GL, Bank AJ, Kass DA, Neutel JM, Preston RA, Oparil S. Advanced glycation end-product cross-link breakers. A novel approach to cardiovascular pathologies related to the aging process. Am J Hypertens. 2004. Vol. 17(12 Pt2):23S-30S

[58] Li JS, Ji T, Su SL, Zhu Y, Chen XL, Shang EX, et al.. Mulberry leaves ameliorate diabetes via regulating metabolic profiling and AGEs/RAGE and p38 MAPK/NF-κB pathway. J Ethnopharmacol. 2022. Vol. 283:114713

[59] Li Q, Wu S, Li SY, Lopez FL, Du M, Kajstura J, et al.. Cardiac-specific overexpression of insulin-like growth factor 1 attenuates aging-associated cardiac diastolic contractile dysfunction and protein damage. Am J Physiol Heart Circ Physiol. 2007. Vol. 292(3):H1398-403

[60] Vinciguerra M, Santini MP, Claycomb WC, Ladurner AG, Rosenthal N.Local IGF-1 isoform protects cardiomyocytes from hypertrophic and oxidative stresses via SirT1 activity. Aging (Albany NY). 2009. Vol. 2(1):43-62

[61] Abdellatif M, Trummer-Herbst V, Heberle AM, Humnig A, Pendl T, Durand S, et al.. Fine-tuning cardiac insulin-like growth factor 1 receptor signaling to promote health and longevity. Circulation. 2022. Vol. 145(25):1853-66

[62] Xi G, Shen X, Wai C, White MF, Clemmons DR. Hyperglycemia induces vascular smooth muscle cell dedifferentiation by suppressing insulin receptor substrate-1-mediated p53/KLF4 complex stabilization. J Biol Chem. 2019. Vol. 294(7):2407-21

[63] Borcherding N, Jia W, Giwa R, Field RL, Moley JR, Kopecky BJ, et al.. Dietary lipids inhibit mitochondria transfer to macrophages to divert adipocyte-derived mitochondria into the blood. Cell Metab. 2022. Vol. 34(10):1499-513.e8

[64] Livshits G, Kalinkovich A. Inflammaging as a common ground for the development and maintenance of sarcopenia, obesity, cardiomyopathy and dysbiosis. Ageing Res Rev. 2019. Vol. 56:100980

[65] Xiang M, Lu Y, Xin L, Gao J, Shang C, Jiang Z, et al.. Role of oxidative stress in reperfusion following myocardial ischemia and its treatments. Oxid Med Cell Longev. 2021. Vol. 2021:6614009

[66] Koonen DP, Febbraio M, Bonnet S, Nagendran J, Young ME, Michelakis ED, et al.. CD36 expression contributes to age-induced cardiomyopathy in mice. Circulation. 2007. Vol. 116(19):2139-47

[67] Lee SR, Heo JH, Jo SL, Kim G, Kim SJ, Yoo HJ, et al.. Progesterone receptor membrane component 1 reduces cardiac steatosis and lipotoxicity via activation of fatty acid oxidation and mitochondrial respiration. Sci Rep. 2021. Vol. 11(1):8781

[68] Teng H, Sui X, Zhou C, Shen C, Yang Y, Zhang P, et al.. Fatty acid degradation plays an essential role in proliferation of mouse female primordial germ cells via the p53-dependent cell cycle regulation. Cell Cycle. 2016. Vol. 15(3):425-31

[69] Tang L, Shi Y, Liao Q, Wang F, Wu H, Ren H, et al.. Reversing metabolic reprogramming by CPT1 inhibition with etomoxir promotes cardiomyocyte proliferation and heart regeneration via DUSP1 ADP-ribosylation-mediated p38 MAPK phosphorylation. Acta Pharm Sin B. 2025. Vol. 15(1):256-77

[70] Gomez LA, Heath SH, Hagen TM. Acetyl-L-carnitine supplementation reverses the age-related decline in carnitine palmitoyltransferase 1 (CPT1) activity in interfibrillar mitochondria without changing the L-carnitine content in the rat heart. Mech Ageing Dev. 2012. Vol. 133(2-3):99-106

[71] Cheng CF, Ku HC, Lin H. PGC-1α as a pivotal factor in lipid and metabolic regulation. Int J Mol Sci. 2018. Vol. 19(11):3447

[72] Corrales P, Vidal-Puig A, Medina-Gómez G. PPARs and metabolic disorders associated with challenged adipose tissue plasticity. Int J Mol Sci. 2018. Vol. 19(7):2124

[73] Rivas DA, Morris EP, Haran PH, Pasha EP, Morais Mda S, Dolnikowski GG, et al.. Increased ceramide content and NFκB signaling may contribute to the attenuation of anabolic signaling after resistance exercise in aged males. J Appl Physiol (1985). 2012. Vol. 113(11):1727-36

[74] Castello L, Maina M, Testa G, Cavallini G, Biasi F, Donati A, et al.. Alternate-day fasting reverses the age-associated hypertrophy phenotype in rat heart by influencing the ERK and PI3K signaling pathways. Mech Ageing Dev. 2011. Vol. 132(6-7):305-14

[75] Aubert G, Martin OJ, Horton JL, Lai L, Vega RB, Leone TC, et al.. The failing heart relies on ketone bodies as a fuel. Circulation. 2016. Vol. 133(8):698-705

[76] Xie S, Xu SC, Deng W, Tang Q. Metabolic landscape in cardiac aging: insights into molecular biology and therapeutic implications. Signal Transduct Target Ther. 2023. Vol. 8(1):114

[77] Uchiyama LF, Nguyen A, Qian K, Cui L, Pham KT, Xiao X, et al.. PPARα regulates ER-lipid droplet protein Calsyntenin-3β to promote ketogenesis in hepatocytes. Proc Natl Acad Sci U S A. 2025. Vol. 122(17):e2426338122

[78] Newman JC, Covarrubias AJ, Zhao M, Yu X, Gut P, Ng CP, et al.. Ketogenic diet reduces midlife mortality and improves memory in aging mice. Cell Metab. 2017. Vol. 26(3):547-57.e8

[79] Zhuang H, Ren X, Zhang Y, Li H, Zhou P. β-Hydroxybutyrate enhances chondrocyte mitophagy and reduces cartilage degeneration in osteoarthritis via the HCAR2/AMPK/PINK1/Parkin pathway. Aging Cell. 2024. Vol. 23(11):e14294

[80] Zhang Q, Zheng M, Sun W, Loers G, Wen M, Wang Q, et al.. Ketogenic diet attenuates microglia-mediated neuroinflammation by inhibiting NLRP3 inflammasome activation via HDAC3 inhibition to activate mitophagy in experimental autoimmune encephalomyelitis. Food Funct. 2025. Vol. 16(12):4731-53

[81] Houston R, Sekine S, Calderon MJ, Seifuddin F, Wang G, Kawagishi H, et al.. Acetylation-mediated remodeling of the nucleolus regulates cellular acetyl-CoA responses. PLoS Biol. 2020. Vol. 18(11):e3000981

[82] Mews P, Donahue G, Drake AM, Luczak V, Abel T, Berger SL. Acetyl-CoA synthetase regulates histone acetylation and hippocampal memory. Nature. 2017. Vol. 546(7658):381-6

[83] Burke AC, Huff MW. ATP-citrate lyase: genetics, molecular biology and therapeutic target for dyslipidemia. Curr Opin Lipidol. 2017. Vol. 28(2):193-200

[84] Bradshaw PC. Acetyl-CoA metabolism and histone acetylation in the regulation of aging and lifespan. Antioxidants (Basel). 2021. Vol. 10(4):572

[85] Sabari BR, Zhang D, Allis CD, Zhao Y. Metabolic regulation of gene expression through histone acylations. Nat Rev Mol Cell Biol. 2017. Vol. 18(2):90-101

[86] Wang N, Wang W, Wang X, Mang G, Chen J, Yan X, et al.. Histone lactylation boosts reparative gene activation post-myocardial infarction. Circ Res. 2022. Vol. 131(11):893-908

[87] Shimkunas R, Hegyi B, Jian Z, Shaw JA, Kazemi-Lari MA, Mitra D, et al.. Mechanical load regulates excitation-Ca²⁺ signaling-contraction in cardiomyocyte. Circ Res. 2021. Vol. 128(6):772-4

[88] Goodman JB, Qin F, Morgan RJ, Chambers JM, Croteau D, Siwik DA, et al.. Redox-resistant SERCA [sarco(endo)plasmic reticulum calcium ATPase] attenuates oxidant-stimulated mitochondrial calcium and apoptosis in cardiac myocytes and pressure overload-induced myocardial failure in mice. Circulation. 2020. Vol. 142(25):2459-69

[89] Alghamdi AM, Boyett MR, Hancox JC, Zhang H.Cardiac pacemaker dysfunction arising from different studies of ion channel remodeling in the aging rat heart. Front Physiol. 2020. Vol. 11:546508

[90] Qin F, Siwik DA, Lancel S, Zhang J, Kuster GM, Luptak I, et al.. Hydrogen peroxide-mediated SERCA cysteine 674 oxidation contributes to impaired cardiac myocyte relaxation in senescent mouse heart. J Am Heart Assoc. 2013. Vol. 2(4):e000184

[91] Kienesberger PC, Pulinilkunnil T, Sung MMY, Nagendran J, Haemmerle G, Kershaw EE, et al.. Myocardial ATGL overexpression decreases the reliance on fatty acid oxidation and protects against pressure overload-induced cardiac dysfunction. Mol Cell Biol. 2012. Vol. 32(4):740-50

[92] Al-U’datt DGF, Tranchant CC, Al-Dwairi A, Alqudah M, Al-Shboul O, Hiram R, et al.. Implications of enigmatic transglutaminase 2 (TG2) in cardiac diseases and therapeutic developments. Biochem Pharmacol. 2022. Vol. 201:115104

[93] Jeong EM, Jin CZ, Jang JH, Zhao ZH, Jin CL, Lee JH, et al.. S-nitrosylation of transglutaminase 2 impairs fatty acid-stimulated contraction in hypertensive cardiomyocytes. Exp Mol Med. 2018. Vol. 50(4):1-11

[94] Zhang S, He Y, Sen B, Wang G. Reactive oxygen species and their applications toward enhanced lipid accumulation in oleaginous microorganisms. Bioresour Technol. 2020. Vol. 307:123234

[95] Grootveld M, Percival BC, Leenders J, Wilson PB. Potential adverse public health effects afforded by the ingestion of dietary lipid oxidation product toxins: significance of fried food sources. Nutrients. 2020. Vol. 12(4):974

[96] Jeong EM, Lee KB, Kim GE, Kim CM, Lee JH, Kim HJ, et al.. Competitive binding of magnesium to calcium binding sites reciprocally regulates transamidase and GTP hydrolysis activity of transglutaminase 2. Int J Mol Sci. 2020. Vol. 21(3):791

[97] Malorni W, Farrace MG, Matarrese P, Tinari A, Ciarlo L, Mousavi-Shafaei P, et al.. The adenine nucleotide translocator 1 acts as a type 2 transglutaminase substrate: implications for mitochondrial-dependent apoptosis. Cell Death Differ. 2009. Vol. 16(11):1480-92

[98] Tomiyama AJ, Carr D, Granberg EM, Major B, Robinson E, Sutin AR, et al.. How and why weight stigma drives the obesity ‘epidemic’ and harms health. BMC Med. 2018. Vol. 16(1):123

[99] Guo J, Chiang WC. Mitophagy in aging and longevity. IUBMB Life. 2022. Vol. 74(4):296-316

[100] Trushina E, McMurray CT. Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases. Neuroscience. 2007. Vol. 145(4):1233-48

[101] Zhang J, Wang H, Slotabec L, Cheng F, Tan Y, Li J. Alterations of SIRT1/SIRT3 subcellular distribution in aging undermine cardiometabolic homeostasis during ischemia and reperfusion. Aging Cell. 2023. Vol. 22(9):e13930

[102] Doan KV, Luongo TS, Ts’olo TT, Lee WD, Frederick DW, Mukherjee S, et al.. Cardiac NAD⁺ depletion in mice promotes hypertrophic cardiomyopathy and arrhythmias prior to impaired bioenergetics. Nat Cardiovasc Res. 2024. Vol. 3(10):1236-48

[103] Lagunas-Rangel FA. Sirtuins in mitophagy: key gatekeepers of mitochondrial quality. Mol Cell Biochem. 2025. Vol. 480(12):5877-96

[104] Zhang F, Li ZQ, Wang YX, Li C, Lu CZ. Mitochondrial Dysfunction as a Therapeutic Target in Diabetic Cardiomyopathy: Progress and Prospects. Cardiovasc Innov Appl. 2025. Vol. 10(1):1-23

[105] Spray L, Richardson G, Haendeler J, Altschmied J, Rumampouw V, Wallis SB, et al.. Cardiovascular inflammaging: mechanisms, consequences, and therapeutic perspectives. Cell Rep Med. 2025. Vol. 6(9):102264

[106] Franceschi C, Garagnani P, Vitale G, Capri M, Salvioli S. Inflammaging and ‘Garb-aging’. Trends Endocrinol Metab. 2017. Vol. 28(3):199-212

[107] Wang Y, Li R, Tong R, Chen T, Sun M, Luo L, et al.. Integrating single-cell RNA and T cell/B cell receptor sequencing with mass cytometry reveals dynamic trajectories of human peripheral immune cells from birth to old age. Nat Immunol. 2025. Vol. 26(2):308-22

[108] Perri A. The NLRP3-inflammasome in health and disease. Int J Mol Sci. 2022. Vol. 23(21):13103

[109] Mo B, Ding Y, Ji Q. NLRP3 inflammasome in cardiovascular diseases: an update. Front Immunol. 2025. Vol. 16:1550226

[110] Hussein AA, Gottdiener JS, Bartz TM, Sotoodehnia N, DeFilippi C, See V, et al.. Inflammation and sudden cardiac death in a community-based population of older adults: the Cardiovascular Health Study. Heart Rhythm. 2013. Vol. 10(10):1425-32

[111] Yan C, Xu Z. Cellular senescence affects cardiac regeneration and repair in ischemic heart disease. Aging Dis. 2021. Vol. 12(2):552-69

[112] Aguilera A, Gómez-González B. Genome instability: a mechanistic view of its causes and consequences. Nat Rev Genet. 2008. Vol. 9(3):204-17

[113] Zhu X, Chen Z, Shen W, Huang G, Sedivy JM, Wang H, et al.. Inflammation, epigenetics, and metabolism converge to cell senescence and ageing: the regulation and intervention. Signal Transduct Target Ther. 2021. Vol. 6(1):245

[114] López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013. Vol. 153(6):1194-217

[115] Wang C, Liu S, Miao W, Ye N, Xie Z, Qiao L, et al.. Intensive blood pressure control in isolated systolic hypertension: a post hoc analysis of a cluster randomized trial. Lancet Reg Health West Pac. 2024. Vol. 48:101127

[116] van Zwieten PA. Isolated systolic hypertension as a treatable risk factor. Neth Heart J. 2002. Vol. 10(1):19-22

[117] Shahbad R, Zermeno E, Razian SA, Maleckis K, Jadidi M, Desyatova A. Effect of stent-graft length and compliance on aortic hemodynamics in a bench-top physiological flow circuit. J Mech Behav Biomed Mater. 2026. Vol. 174:107269

[118] Giudici A, Grillo A, Scalise F, Reesink KD, Delhaas T, Salvi P, et al.. Beat-to-beat variability of aortic pulse wave velocity: implications for aortic stiffness measurements. J Hypertens. 2025. Vol. 43(4):589-97

[119] Reinhart M, Puil L, Salzwedel DM, Wright JM. First-line diuretics versus other classes of antihypertensive drugs for hypertension. Cochrane Database Syst Rev. 2023. Vol. 7(7):CD008161

[120] Zhang Z, Wang Y, Chen X, Wu C, Zhou J, Chen Y, et al.. The aging heart in focus: the advanced understanding of heart failure with preserved ejection fraction. Ageing Res Rev. 2024. Vol. 101:102542

[121] Xiao F, Qi J, Ma S, Sun L, Sun Y. Research progress on the role and mechanism in the change of cardiac structure and function of cardiac fibrosis in the elderly. Cardiol Rev. 2025. [Cross Ref]

[122] Tyrrell DJ, Blin MG, Song J, Wood SC, Zhang M, Beard DA, et al..Age-associated mitochondrial dysfunction accelerates atherogenesis. Circ Res. 2020. Vol. 126(3):298-314

[123] Habel N, Infeld M, Lustgarten D, Meyer M. Atrial fibrillation and heart failure with preserved ejection fraction “twindemic”-shared root causes and treatment targets. Heart Rhythm. 2025. Vol. 22(5):1188-96

[124] Kagami K, Harada T, Ishii H, Obokata M. Key phenotypes of heart failure with preserved ejection fraction: pathophysiologic mechanisms and potential treatment strategies. Cardiol Clin. 2022. Vol. 40(4):415-29

[125] Yu J, Zhou GX, Guo YZ, Long Y. Inflammation in Heart Failure: Mechanisms and Therapeutic Strategies. Cardiovasc Innov Appl. 2025. Vol. 10(1):1-17

[126] Talha KM, Anker SD, Butler J. SGLT-2 inhibitors in heart failure: a review of current evidence. Int J Heart Fail. 2023. Vol. 5(2):82-90

[127] Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol. 1998. Vol. 82(8A):2N-9N

[128] He B, Cheng Y, Wang J, Zhan Y, Liu Y. Cellular interactions and Ion channel signatures in atrial fibrillation remodeling: insights from single-cell analysis and machine learning. Front Cardiovasc Med. 2025. Vol. 12:1615574

[129] Gao P, Gao X, Xie B, Tse G, Liu T. Aging and atrial fibrillation: a vicious circle. Int J Cardiol. 2024. Vol. 395:131445

[130] Sur NB. Stroke by stroke: the compounding burden of prior strokes on outcomes in atrial fibrillation. J Am Heart Assoc. 2025. Vol. 14(2):e039646

[131] Saraiva JFK. Stroke prevention with oral anticoagulants: summary of the evidence and efficacy measures as an aid to treatment choices. Cardiol Ther. 2018. Vol. 7(1):15-24

[132] Perazza LR, Brown-Borg HM, Thompson LV.Physiological Systems in Promoting Frailty. Compr Physiol. 2022. Vol. 12(3):3575-620

[133] Li T, Thoen ZE, Applebaum JM, Khalil RA. Menopause-related changes in vascular signaling by sex hormones. J Pharmacol Exp Ther. 2025. Vol. 392(4):103526

[134] Veronese N, Sigeirsdottir K, Eiriksdottir G, Marques EA, Chalhoub D, Phillips CL, et al.. Frailty and risk of cardiovascular diseases in older persons: the age, gene/environment susceptibility-reykjavik study. Rejuvenation Res. 2017. Vol. 20(6):517-24

[135] Piérard S, Seldrum S, de Meester C, Pasquet A, Gerber B, Vancraeynest D, et al.. Incidence, determinants, and prognostic impact of operative refusal or denial in octogenarians with severe aortic stenosis. Ann Thorac Surg. 2011. Vol. 91(4):1107-12

[136] Yeh JK, Lin MH, Wang CY. Telomeres as therapeutic targets in heart disease. JACC Basic Transl Sci. 2019. Vol. 4(7):855-65

[137] Jung HJ, Suh Y. Circulating miRNAs in ageing and ageing-related diseases. J Genet Genomics. 2014. Vol. 41(9):465-72

[138] Wang Z, Li W, Liu W, Tian J. Gender is a determinant of carotid artery stiffness independent of age and blood pressure. Br J Radiol. 2021. Vol. 94(1119):20200796

[139] Ji Q, Jiang X, Wang M, Xin Z, Zhang W, Qu J, et al.. Multimodal omics approaches to aging and age-related diseases. Phenomics. 2024. Vol. 4(1):56-71

[140] Zhang SY, Yang YH, Wen R, Yang N, Feng SS, Zhang TN. Cellular and molecular mechanisms underlying cardiovascular aging. Cell Mol Biol Lett. 2025. Vol. 30(1):125

[141] Jiang L, Ding H, Lee D, Chun B. The optimal type and dose of exercise interventions on VEGF levels in healthy individuals, as well as obesity and chronic disease populations: a network meta-analysis. Biomedicines. 2025. Vol. 13(10):2548

[142] Itsiopoulos C, Mayr HL, Thomas CJ. The anti-inflammatory effects of a Mediterranean diet: a review. Curr Opin Clin Nutr Metab Care. 2022. Vol. 25(6):415-22

[143] Damigou E, Anastasiou C, Chrysohoou C, Barkas F, Tsioufis C, Pitsavos C, et al.. Prevented fractions of cardiovascular disease cases, by long-term adherence to the Mediterranean diet; the ATTICA study (2002-2022). Nutr Metab Cardiovasc Dis. 2025. Vol. 35(5):103777

[144] Bonaccio M, Di Castelnuovo A, Costanzo S, Ruggiero E, Esposito S, Panzera T, et al.. Mediterranean diet is associated with lower all-cause and cardiovascular mortality among long-term cancer survivors. JACC CardioOncol. 2024. Vol. 6(4):602-4

[145] Lages M, Carmo-Silva S, Barros R, Guarino MP. Effects of time-restricted eating on body composition, biomarkers of metabolism, inflammation, circadian system and oxidative stress in overweight and obesity: an exploratory review. Proc Nutr Soc. 2026. Vol. 85(1):13-22

[146] Faramia J, Ostinelli G, Drolet-Labelle V, Picard F, Tchernof A. Metabolic adaptations after bariatric surgery: adipokines, myokines and hepatokines. Curr Opin Pharmacol. 2020. Vol. 52:67-74

[147] Ali Raza J, Movahed A. Use of cardiovascular medications in the elderly. Int J Cardiol. 2002. Vol. 85(2-3):203-15

[148] Apperloo EM, Neuen BL, Fletcher RA, Jongs N, Anker SD, Bhatt DL, et al..Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials. Lancet Diabetes Endocrinol. 2024. Vol. 12(8):545-57

[149] Guarente L, Sinclair DA, Kroemer G.Human trials exploring anti-aging medicines. Cell Metab. 2024. Vol. 36(2):354-76

[150] Ard J, Fitch A, Fruh S, Herman L. Weight loss and maintenance related to the mechanism of action of glucagon-like peptide 1 receptor agonists. Adv Ther. 2021. Vol. 38(6):2821-39

[151] Morciano C, Gugliandolo S, Capece U, Di Giuseppe G, Mezza T, Ciccarelli G, et al.. SGLT2 inhibition and adipose tissue metabolism: current outlook and perspectives. Cardiovasc Diabetol. 2024. Vol. 23(1):449

[152] Pandey AK, Bhatt DL, Pandey A, Marx N, Cosentino F, Pandey A, et al.. Mechanisms of benefits of sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction. Eur Heart J. 2023. Vol. 44(37):3640-51

[153] Heerspink HJ, Perkins BA, Fitchett DH, Husain M, Cherney DZ. Sodium glucose cotransporter 2 inhibitors in the treatment of diabetes mellitus: cardiovascular and kidney effects, potential mechanisms, and clinical applications. Circulation. 2016. Vol. 134(10):752-72

[154] Meguro M, Doi F, Soneda T, Furuzono S, Konishi M, Harada J, et al.. Discovery of DS-1150b, a novel xanthene compound for activating GLUT 4 translocation. Bioorg Med Chem Lett. 2025. Vol. 122:130191

[155] Pekala J, Patkowska-Sokoła B, Bodkowski R, Jamroz D, Nowakowski P, Lochyński S, et al.. L-carnitine--metabolic functions and meaning in humans life. Curr Drug Metab. 2011. Vol. 12(7):667-78

[156] Wang ZY, Liu YY, Liu GH, Lu HB, Mao CY. l-Carnitine and heart disease. Life Sci. 2018. Vol. 194:88-97

[157] Yurista SR, Chong CR, Badimon JJ, Kelly DP, de Boer RA, Westenbrink BD. Therapeutic potential of ketone bodies for patients with cardiovascular disease: JACC state-of-the-art review. J Am Coll Cardiol. 2021. Vol. 77(13):1660-9

[158] Salgado-Almario J, Vicente M, Molina Y, Martinez-Sielva A, Vincent P, Domingo B, et al.. Simultaneous imaging of calcium and contraction in the beating heart of zebrafish larvae. Theranostics. 2022. Vol. 12(3):1012-29

[159] Lin RL, Frazier HN, Anderson KL, Case SL, Ghoweri AO, Thibault O. Sensitivity of the S1 neuronal calcium network to insulin and Bay-K 8644 in vivo: relationship to gait, motivation, and aging processes. Aging Cell. 2022. Vol. 21(7):e13661

[160] Estrada-Soto S, Rendon-Vallejo P, Villalobos-Molina R, Millán-Pacheco C, Vázquez M, Hernández-Borja F, et al.. 6-amino-3-methyl-4-(2-nitrophenyl)-1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile shows antihypertensive and vasorelaxant action via calcium channel blockade. Drug Res (Stuttg). 2022. Vol. 72(1):53-60

[161] Lu Y, Li L, Zhao X, Huang W, Wen W. Beta blocker metoprolol protects against contractile dysfunction in rats after coronary microembolization by regulating expression of myocardial inflammatory cytokines. Life Sci. 2011. Vol. 88(23-24):1009-15

[162] Liang C, Xiaonan L, Xiaojun C, Changjiang L, Xinsheng X, Guihua J, et al.. Effect of metoprolol on vulnerable plaque in rabbits by changing shear stress around plaque and reducing inflammation. Eur J Pharmacol. 2009. Vol. 613(1-3):79-85

[163] Haas MJ, Kurban W, Shah H, Onstead-Haas L, Mooradian AD. Beta blockers suppress dextrose-induced endoplasmic reticulum stress, oxidative stress, and apoptosis in human coronary artery endothelial cells. Am J Ther. 2016. Vol. 23(6):e1524-e31

[164] Gounder SS, Kannan S, Devadoss D, Miller CJ, Whitehead KJ, Odelberg SJ, et al.. Impaired transcriptional activity of Nrf2 in age-related myocardial oxidative stress is reversible by moderate exercise training. PLoS One. 2012. Vol. 7(9):e45697

[165] Hong W, Zeng X, Wang H, Tan X, Tian Y, Hu H, et al.. PGC-1α loss promotes mitochondrial protein lactylation in acetaminophen-induced liver injury via the LDHB-lactate axis. Pharmacol Res. 2024. Vol. 205:107228

[166] Mohanty RR, Padhy BM, Das S, Meher BR. Therapeutic potential of N-acetyl cysteine (NAC) in preventing cytokine storm in COVID-19: review of current evidence. Eur Rev Med Pharmacol Sci. 2021. Vol. 25(6):2802-7

[167] Smeyne M, Smeyne RJ. Glutat-hione metabolism and Parkinson’s disease. Free Radic Biol Med. 2013. Vol. 62:13-25

[168] Cho YS. Genipin, an inhibitor of UCP2 as a promising new anticancer agent: a review of the literature. Int J Mol Sci. 2022. Vol. 23(10):5637

[169] Hua J, Zhang Z, Zhang L, Sun Y, Yuan Y. UCP-2 inhibitor enhanced the efficacy of trastuzumab against HER2 positive breast cancer cells. Cancer Chemother Pharmacol. 2021. Vol. 88(4):633-42

[170] Amini L, Chekini R, Nateghi MR, Haghani H, Jamialahmadi T, Sathyapalan T, et al.. The effect of combined vitamin C and vitamin E supplementation on oxidative stress markers in women with endometriosis: a randomized, triple-blind placebo-controlled clinical trial. Pain Res Manag. 2021. Vol. 2021:5529741

[171] Ludke A, Sharma AK, Bagchi AK, Singal PK. Subcellular basis of vitamin C protection against doxorubicin-induced changes in rat cardiomyocytes. Mol Cell Biochem. 2012. Vol. 360(1-2):215-24

[172] Yu D, Xiong J, Gao Y, Li J, Zhu D, Shen X, et al.. Resveratrol activates PI3K/AKT to reduce myocardial cell apoptosis and mitochondrial oxidative damage caused by myocardial ischemia/reperfusion injury. Acta Histochem. 2021. Vol. 123(5):151739

[173] Breuss JM, Atanasov AG, Uhrin P. Resveratrol and its effects on the vascular system. Int J Mol Sci. 2019. Vol. 20(7):1523

[174] Rauf A, Imran M, Butt MS, Nadeem M, Peters DG, Mubarak MS. Resveratrol as an anti-cancer agent: a review. Crit Rev Food Sci Nutr. 2018. Vol. 58(9):1428-47

[175] Yen HC, Chen FY, Chen SW, Huang YH, Chen YR, Chen CW. Effect of mitochondrial dysfunction and oxidative stress on endogenous levels of coenzyme Q(10) in human cells. J Biochem Mol Toxicol. 2011. Vol. 25(5):280-9

[176] Charles AL, Meyer A, Dal-Ros S, Auger C, Keller N, Ramamoorthy TG, et al.. Polyphenols prevent ageing-related impairment in skeletal muscle mitochondrial function through decreased reactive oxygen species production. Exp Physiol. 2013. Vol. 98(2):536-45

[177] Campisi M, Cannella L, Paccagnella O, Brazzale AR, Agnolin A, et al.. Grothe T, Unveiling the geroprotective potential of Monarda didyma L.: insights from in vitro studies and a randomized clinical trial on slowing biological aging and improving quality of life. Geroscience. 2025. Vol. 47(3):4253-90

[178] Zhang T, Zhou L, Makarczyk MJ, Feng P, Zhang J. The anti-aging mechanism of metformin: from molecular insights to clinical applications. Molecules. 2025. Vol. 30(4):816

[179] Meddeb M, Koleini N, Keykhaei M, Liu T, Rhodehamel M, Mandarano L, et al.. ATP-citrate lyase supports cardiac function and NAD⁺/NADH balance and is depressed in human failing myocardium. JACC Basic Transl Sci. 2025. Vol. 10(7):101301

[180] Ling S, Dexter A, Race AM, Sharma S, Hamm G, Polanska UM, et al.. Use of metabolic imaging to monitor heterogeneity of tumour response following therapeutic mTORC1/ 2 pathway inhibition. Dis Model Mech. 2025. Vol. 18(2):DMM050804

[181] Zhou AJ, Xiong ZE, Wang L, Chen XX, Wang ZP, Zhang YD, et al.. Long-term administration of nicotinamide mononucleotide mitigates high-fat-diet-induced physiological decline in aging Mice. J Nutr. 2025. Vol. 155(1):237-49

[182] Kulkarni AS, Gubbi S, Barzilai N. Benefits of metformin in attenuating the hallmarks of aging. Cell Metab. 2020. Vol. 32(1):15-30

[183] Tran HH, Thu A, Twayana AR, Fuertes A, Gonzalez M, Basta M, et al.. The autonomic nexus: neuromodulation as a new frontier in arrhythmia therapy. Cardiol Rev. 2025. [Cross Ref]

[184] de Campos MCAV, Moraes VRY, Daher RF, Micheleto JPC, de Campos LAV, Barros GFA, et al.. Pulsed-field ablation versus thermal ablation for atrial fibrillation: a meta-analysis. Heart Rhythm O2. 2024. Vol. 5(6):385-95

[185] Liberale L, Tual-Chalot S, Sedej S, Ministrini S, Georgiopoulos G, Grunewald M, et al.. Roadmap for alleviating the manifestations of ageing in the cardiovascular system. Nat Rev Cardiol. 2025. Vol. 22(8):577-605

[186] Carreras-Gallo N, Dargham R, Thorpe SP, Warren S, Mendez TL, Smith R, et al..Effects of a natural ingredients-based intervention targeting the hallmarks of aging on epigenetic clocks, physical function, and body composition: a single-arm clinical trial. Aging (Albany NY). 2025. Vol. 17(3):699-725

[187] Forman DE, Kuchel GA, Newman JC, Kirkland JL, Volpi E, Taffet GE, et al.. Impact of geroscience on therapeutic strategies for older adults with cardiovascular disease: JACC Scientific Statement. J Am Coll Cardiol. 2023. Vol. 82(7):631-47

[188] Patel AP, Wang M, Ruan Y, Koyama S, Clarke SL, Yang X, et al.. A multi-ancestry polygenic risk score improves risk prediction for coronary artery disease. Nat Med. 2023. Vol. 29(7):1793-803

[189] Tian T, Xue Y, Song Z, Jin-Smith B, Barkin J, Ottallah M, et al.. Targeted clearance of senescent cells alleviates alcohol-associated liver disease by restoring cellular function and immune balance. Geroscience. 2025. [Cross Ref]

[190] Wu D, Tan B, Cheng Z, Li H, Li H, Yin Y, et al.. Elevating cytosolic NADPH metabolism in endothelial cells ameliorates vascular aging. Nat Commun. 2025. Vol. 16(1):9667

[191] Mathews SC, McShea MJ, Hanley CL, Ravitz A, Labrique AB, Cohen AB. Digital health: a path to validation. npj Digit Med. 2019. Vol. 2(1):38

[192] Wang Y, Liu M, Chen X, Wang S, Li J, Sun Y, et al.. The drug discovery and therapeutic nano-strategies targeting cellular senescence. Mater Today Bio. 2025. Vol. 35:102480

[193] Bawamia B, Spray L, Wangsaputra VK, Bennaceur K, Vahabi S, Stellos K, et al.. Activation of telomerase by TA-65 enhances immunity and reduces inflammation post myocardial infarction. Geroscience. 2023. Vol. 45(4):2689-705

[194] Wierich MC, Schipke J, Brandenberger C, Abdellatif M, Eisenberg T, Madeo F, et al.. Cardioprotection by spermidine does not depend on structural characteristics of the myocardial microcirculation in aged mice. Exp Gerontol. 2019. Vol. 119:82-8

[195] Liu S, Faitg J, Tissot C, Konstantopoulos D, Laws R, Bourdier G, et al.. Urolithin A provides cardioprotection and mitochondrial quality enhancement preclinically and improves human cardiovascular health biomarkers. iScience. 2025. Vol. 28(2):111814

[196] Ye JL, Grieger K, Lu D, Brandenberger C, Juchem M, Jordan M, et al.. Telomerase modRNA offers a novel RNA-based approach to treat human pulmonary fibrosis. Aging Cell. 2025. Vol. 24(11):e70240

[197] Roig-Soriano J, Griñán-Ferré C, Espinosa-Parrilla JF, Abraham CR, Bosch A, Pallàs M, et al.. AAV-mediated expression of secreted and transmembrane αKlotho isoforms rescues relevant aging hallmarks in senescent SAMP 8 mice. Aging Cell. 2022. Vol. 21(4):e13581

[198] Nahar N, Sohag MSU. Advance-ments in mitochondrial-targeted antioxidants: organelle-specific drug delivery for disease management. Adv Redox Res. 2025. Vol. 17:100142

[199] Parker DC, Bartlett BN, Cohen HJ, Fillenbaum G, Huebner JL, Kraus VB, et al.. Association of blood chemistry quantifications of biological aging with disability and mortality in older adults. J Gerontol A Biol Sci Med Sci. 2020. Vol. 75(9):1671-9

[200] Woods B, Ten Ham R, Claxton K. Equitable access to costly new drugs. Br Med J. 2025. Vol. 391:r2292

[201] Peng Y, Ding L, Xiao Z, Song M, Lv J, Liu GH. Ethical concerns in aging research: perspectives of global frontline researchers. Sci China Life Sci. 2024. Vol. 67(10):2149-56

[202] Mulat M, Banicod RJS, Tabassum N, Javaid A, Kim TH, Kim YM, et al.. Application of artificial intelligence in microbial drug discovery: unlocking new frontiers in biotechnology. J Microbiol Methods. 2025. Vol. 237:107232

[203] Ahadi S, Zhou W, Schüssler-Fiorenza Rose SM, Sailani MR, Contrepois K, Avina M, et al.. Personal aging markers and ageotypes revealed by deep longitudinal profiling. Nat Med. 2020. Vol. 26(1):83-90

[204] Moskalev AA. Potential geroprotectors -from bench to clinic. Biochemistry (Mosc). 2023. Vol. 88(11):1732-8

[205] Brouwers SJ, Janssens GE, Spiegel T. Attitudes towards geroprotection: measuring willingness, from lifestyle changes to drug use. Front Aging. 2024. Vol. 5:1440661